Allogeneic mesenchymal stem cells: agents of immune modulation

Area of Science:

• Immunology
• Regenerative Medicine
• Cell Therapy

Background:

• Adult mesenchymal stem cells (MSC) exhibit potent immunosuppressive properties.
• MSC-mediated immune suppression facilitates allogeneic transplantation and immune deviation.
• Understanding MSC interactions with innate immunity is crucial for therapeutic applications.

Purpose of the Study:

• To review recent advances in the mechanistic understanding of mesenchymal stromal/stem cell (MSC) interactions with innate immunity.
• To explore the role of Toll-like receptor signaling in modulating MSC function.
• To survey MSC-mediated suppression of T cell responses and induction of regulatory T cells.

Main Methods:

• Literature review of recent advances in MSC immunomodulation.
• Analysis of Toll-like receptor signaling pathways affecting MSC.
• Survey of mechanisms underlying MSC effects on T and B cells.

Main Results:

• Innate immune signals, particularly Toll-like receptor signaling, can "license" MSCs, enhancing their immunomodulatory capacity.
• MSCs effectively suppress T cell proliferation and induce regulatory T cell populations.
• Conflicting data exist regarding MSC influence on B cell function.

Conclusions:

• MSC-based therapies hold promise for regenerative medicine due to their immunosuppressive capabilities.
• Further research is needed to elucidate the precise mechanisms of MSC-mediated immune modulation, especially concerning B cells.
• Defining the limits of MSC immune modulation is essential for optimizing future clinical applications.